References
- Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-42. https://doi.org/10.1038/nature01658
- Walsh MC, Kim N, Kadono Y, Rho J, Lee SY, Lorenzo J, Choi Y. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol. 2006; 24:33-63. https://doi.org/10.1146/annurev.immunol.24.021605.090646
- Nakashima T, Takayanagi H. New regulation mechanisms of osteoclast differentiation. Ann N Y Acad Sci. 2011;1240: E13-E18. https://doi.org/10.1111/j.1749-6632.2011.06373.x
- Jun JH, Kim HK, Woo KM, Kim GS, Baek JH. Increase in intracellular calcium is necessary for RANKL induction by high extracellular calcium. Int J Oral Biol. 2005;30:9-15.
- Lee J, Kim K, Kim N. Negative regulators in RANKLinduced osteoclastogenesis. Int J Oral Biol. 2007;32:1-5.
-
Feske S, Okamura H, Hogan PG, Rao A.
$Ca^{2+}$ / calcineurin signalling in cells of the immune system. Biochem Biophys Res Commun. 2003;311:1117-1132. https://doi.org/10.1016/j.bbrc.2003.09.174 - Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003; 17:2205-2232. https://doi.org/10.1101/gad.1102703
- Oh-hora M, Rao A. The calcium/NFAT pathway: role in development and function of regulatory T cells. Microbes Infect. 2009;11:612-619. https://doi.org/10.1016/j.micinf.2009.04.008
- Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, Sakai H. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun. 2000;275:768-775. https://doi.org/10.1006/bbrc.2000.3379
- Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol. 2002;20:795-823. https://doi.org/10.1146/annurev.immunol.20.100301.064753
- Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007;7:292-304. https://doi.org/10.1038/nri2062
- Rusnak F, Mertz P. Calcineurin: form and function. Physiol Rev. 2000;80:1483-1521. https://doi.org/10.1152/physrev.2000.80.4.1483
- Schulz RA, Yutzey KE. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev Biol. 2004;266:1-16. https://doi.org/10.1016/j.ydbio.2003.10.008
- Borel JF, Feurer C, Gubler HU, Stahelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976;6:468-475. https://doi.org/10.1007/BF01973261
- Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki H, Ochiai T. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo). 1987;40:1256-1265. https://doi.org/10.7164/antibiotics.40.1256
- Okamoto K, Takayanagi H. Regulation of bone by the adaptive immune system in arthritis. Arthritis Res Ther. 2011;13:219. https://doi.org/10.1186/ar3323
- Horwood NJ, Kartsogiannis V, Quinn JM, Romas E, Martin TJ, Gillespie MT. Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun. 1999;265:144-150. https://doi.org/10.1006/bbrc.1999.1623
- Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999;402:304-309. https://doi.org/10.1038/46303
- Lubberts E, van den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, Joosten LA, van den Berg WB. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol. 2003;170:2655-2662.
- Yuvaraj S, Griffin AC, Sundaram K, Kirkwood KL, Norris JS, Reddy SV. A novel function of CXCL13 to stimulate RANK ligand expression in oral squamous cell carcinoma cells. Mol Cancer Res. 2009;7:1399-1407. https://doi.org/10.1158/1541-7786.MCR-08-0589
- Morgan AJ, Jacob R. Ionomycin enhances Ca2+ influx by stimulating store-regulated cation entry and not by a direct action at the plasma membrane. Biochem J. 1994;300: 665-672. https://doi.org/10.1042/bj3000665
-
Zhao Y, Koebis M, Suo S, Ohno S, Ishiura S. Regulation of the alternative splicing of sarcoplasmic reticulum
$Ca^{2+}$ -ATPase1 (SERCA1) by phorbol 12-myristate 13-acetate (PMA) via a PKC pathway. Biochem Biophys Res Commun. 2012;423:212-217. https://doi.org/10.1016/j.bbrc.2012.05.033 - Lee HL, Bae OY, Baek KH, Kwon A, Hwang HR, Qadir AS, Park HJ, Woo KM, Ryoo HM, Baek JH. High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-kappaB ligand in osteoblasts. Bone. 2011;49:242-249. https://doi.org/10.1016/j.bone.2011.04.006
- Boss V, Talpade DJ, Murphy TJ. Induction of NFAT-mediated transcription by Gq-coupled receptors in lymphoid and non-lymphoid cells. J Biol Chem. 1996;271:10429- 10432. https://doi.org/10.1074/jbc.271.18.10429
- Flanagan WM, Corthesy B, Bram RJ, Crabtree GR. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature. 1991;352:803-807. https://doi.org/10.1038/352803a0
- Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilincyclosporin A and FKBP-FK506 complexes. Cell. 1991;66: 807-815. https://doi.org/10.1016/0092-8674(91)90124-H
- O'Keefe SJ, Tamura J, Kincaid RL, Tocci MJ, O'Neill EA. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature. 1992;357:692-694. https://doi.org/10.1038/357692a0
- Pinkas-Kramarski R, Edelman R, Stein R. Indications for selective coupling to phosphoinositide hydrolysis or to adenylate cyclase inhibition by endogenous muscarinic receptor subtypes M3 and M4 but not by M2 in tumor cell lines. Neurosci Lett. 1990;108:335-340. https://doi.org/10.1016/0304-3940(90)90663-T
- Okamoto K, Takayanagi H. Osteoclasts in arthritis and Th17 cell development. Int Immunopharmacol. 2011;11: 543-548. https://doi.org/10.1016/j.intimp.2010.11.010